Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX) has a 85-report earnings history dating back to Oct 21, 2004. Its average absolute post-earnings move is ±5.63%, and 49.4% of those reactions were positive. Its largest post-earnings gain was +27.76% (Feb 26, 2024) and its largest decline was -20.99% (Nov 04, 2014). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings reactions
How CLDX moved on each past earnings report.
Earnings Impact
Total Earnings
85
Avg Abs. Movement
±5.63%
Positive %
49.4%
Negative %
50.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☽ POST | +1.91% | open_in_new |
| Feb 25, 2026 | ☽ POST | -0.58% | open_in_new |
| Nov 10, 2025 | ☽ POST | +7.5% | open_in_new |
| Aug 07, 2025 | ☽ POST | -2.59% | open_in_new |
Earnings Count
85
Total earnings in dataset
Avg Abs. Movement
±5.63%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260715 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
Frequently asked about CLDX earnings
When does Celldex Therapeutics, Inc. report earnings next? expand_more
Celldex Therapeutics, Inc. (CLDX)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CLDX stock move after earnings? expand_more
Over 85 reports, CLDX has moved an average of ±5.63% the session after earnings, closing higher 49.4% of the time.
What was CLDX's biggest post-earnings move? expand_more
CLDX's largest post-earnings gain on record was +27.76% on Feb 26, 2024, and its largest decline was -20.99% on Nov 04, 2014.
Where can I find Celldex Therapeutics, Inc.'s SEC filings? expand_more
All of Celldex Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07